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Purpose: This study was designed to evaluate the time-course of contrast enhancement to 
improve imaging and quantification of subcutaneous tumors in rodents using different 
contrast agents for Computed Tomography imaging. 
 
Procedures: 4 SCID mice received subcutaneous injection of human bladder carcinoma 
cells in the right flank. Tumors were imaged 4 weeks after inoculation with a small-animal 
CT-scanner using two different iodinated contrast agents: FenestraTM-VC and Iopamiro-
300R. Two types of studies were performed: a dynamic-planar study during the first 10 
minutes after the injection of the contrast agent [8 shots/second during 200 seconds and 1 
shot/second during 400 seconds]; and a static tomographic studies at time points 15, 30 
and 50 minutes. Images were reconstructed using a modified FDK-algorithm. Regions of 
interest (ROIs) were drawn in the dynamic planar study over tumor and liver. On the static 
tomographic studies the following ROIs were drawn: tumor, right ventricle, liver, kidney, 
spleen, muscle, bladder and air. 
 
Results: No significant differences in contrast enhancenment between contrast agents 
were observed in the dynamic planar study. However, significant signal increases were 
observed in tumor, liver, kidney, spleen, muscle and bladder with Iopamiro in the static 
tomographic studies. Tumor peak enhancement occurred 15 min after the iopamiro 
injection, with an observed density increase of 158 HU. In the case of Fenestra, tumor peak 
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enhancement occurred at 30 min with a density increment of 27 HU. The HU in air 
remained constant. Results about the correlation between iopamiro enhancement and 
vasculature enhancement provided by Fenestra are in progress. 
 
Conclusions: Differences in contrast enhancement at different tissues are due to the 
different properties of the contrast agent. Iopamiro diffused rapidly from the vascular into 
the extravascular space, while Fenestra remained in the vascular space. These two 
behaviours may facilitate the characterization of experimental tumors in rodents using 
Computed Tomography. 
  
